17/02/2010 Author: Elana Margulies

Ex-Putnam veteran launches maiden fund

Brian DeChristopher, formerly with Putnam Investments, has launched his maiden hedge fund, HFMWeek has learned.
After forming Boston-based Chordant Capital Partners, the Chordant Lifesciences Fund debuted this month. The offering is a long/short global healthcare and life sciences fund with a slight long-bias. It has 20 long positions and 20-30 shorts. Its capacity is $500m.

DeChristopher, the fund’s portfolio manager and founder, was a healthcare analyst and portfolio manager at Putnam Investments.

Last year, the BarclayHedge healthcare and biotechnology index returned 28% and is down slightly at the start of 2010.
Stocks in the healthcare sector continue to trade at a greater discount to historical premiums. Today healthcare stocks discount to the S&P 500 is around 15% and was trading at an 11% discount between 2005 and 2008.

The fund has a $250,000 investment minimum, 1.5/15 fees and a one-year lockup. Jefferies & Co and JP Morgan are the prime brokers.

Post a comment

Post a comment…

Be the first to comment on this article!

29/02/2012

UK: Opera Standards: The Challenge and Opportunities of Standardising Hedge Fund Risk Reporting

Join us and our panel of experts for HFMWeek's Subscribers' Club February's UK breakfast briefing…

Read More

29/02/2012

US: Endowments and Foundations in Hedge Funds

The next US HFMWeek Subscribers' Club breakfast, will take place on Wednesday February 29. Join…

Read More

02/02/2011

European Hedge Fund Services Awards 2012

HFMWeek's European Hedge Fund Services Awards are designed to recognise companies that have outperformed...

Read More

Search HFMWeek